Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Meng-Nan Yuan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Me…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Vascular Remodeling, Apoptosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Health Research Program of Zhejiang, the Chinese Medicine Research Program of Zhejiang Province, Zhejiang Province Natural Science Foundation of China.
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a chronic progressive vascular disease characterized by abnormal pulmonary vascular resistance and pulmonary artery pressure. The major structural alteration during PH is pulmonary vascular remodelling, which is mainly caused by the imbalance between proliferation and apoptosis of pulmonary vascular cells. Previously, it was thought that apoptosis was the only type of programmed cell death (PCD). Soon afterward, other types of PCD have been identified, including autophagy, pyroptosis, ferroptosis and necroptosis. In this review, we summarize the role of the above five forms of PCD in mediating pulmonary vascular remodelling, and discuss their guiding significance for PH treatment. The current review could provide a better understanding of the correlation between PCD and pulmonary vascular remodelling, contributing to identify new PCD‐associated drug targets for PH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
ORCID-Profile: Meng-Nan Yuan, Qi-Yue Wang, Xiao-Zhou Zou
Förderung
- Medical and Health Research Program of Zhejiang
- the Chinese Medicine Research Program of Zhejiang Province
- Zhejiang Province Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Yuan, M. N., Liu, T., Cai, A. Q., Zhan, Z., Cheng, Y. L., Wang, Q. Y., Xia, Y. X., Shen, N. E., Huang, P., & Zou, X. Z. (2024). Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70003
Vancouver
Yuan MN, Liu T, Cai AQ, Zhan Z, Cheng YL, Wang QY, et al. Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70003
BibTeX
@article{Yuan2024,
author = {Yuan, Meng-Nan and Liu, Ting and Cai, An-Qi and Zhan, Zibo and Cheng, Yi-Li and Wang, Qi-Yue and Xia, Yu-Xuan and Shen, Nong-Er and Huang, Ping and Zou, Xiao-Zhou},
title = {Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70003}
}
EUVIMED